Top

Journal of Endocrinological Investigation

Published in:

01-01-2018 | Short Review

Role of Jagged1-Notch pathway in thyroid development

Authors: F. Marelli, L. Persani

Published in: Journal of Endocrinological Investigation | Issue 1/2018

Abstract

The zebrafish thyroid gland shows a unique pattern of growth. Despite the lack of a compact gland, the zebrafish thyroid tissue originates from the pharyngeal endoderm and the main genes involved in its patterning and early development are conserved between zebrafish and mammals. In recent years, the research has been focused to the search of novel candidate genes and environmental factors underlying congenital hypothyroidism. Among these, it has been demonstrated that the Notch signalling plays a central role during zebrafish thyroid development. In this review, we will provide an overview of the current knowledge of the distinct roles of the Notch signalling and of the jag1a and jag1b ligands during the different phases of thyroid organogenesis. Furthermore, we will discuss the role of JAG1 variants in congenital thyroid defects.

Zorn AM, Wells JM (2009) Vertebrate endoderm development and organ formation. Annu Rev Cell Dev Biol 25:221–251. doi:10.1146/annurev.cellbio.042308.113344 CrossRefPubMedPubMedCentral

de Filippis T, Marelli F, Nebbia G, Porazzi P, Corbetta S, Fugazzola L, Gastaldi R, Vigone MC, Biffanti R, Frizziero D, Mandara L, Prontera P, Salerno M, Maghnie M, Tiso N, Radetti G, Weber G, Persani L (2016) JAG1 Loss-of-function variations as a novel predisposing event in the pathogenesis of congenital thyroid defects. J Clin Endocrinol Metab 101(3):861–870. doi:10.1210/jc.2015-3403 CrossRefPubMed

Ferretti E, Tosi E, Po A, Scipioni A, Morisi R, Espinola MS, Russo D, Durante C, Schlumberger M, Screpanti I, Filetti S, Gulino A (2008) Notch signaling is involved in expression of thyrocyte differentiation markers and is down-regulated in thyroid tumors. J Clin Endocrinol Metab 93(10):4080–4087. doi:10.1210/jc.2008-0528 CrossRefPubMed

Porazzi P, Marelli F, Benato F, de Filippis T, Calebiro D, Argenton F, Tiso N, Persani L (2012) Disruptions of global and JAGGED1-mediated notch signaling affect thyroid morphogenesis in the zebrafish. Endocrinology 153(11):5645–5658. doi:10.1210/en.2011-1888 CrossRefPubMed

Alt B, Reibe S, Feitosa NM, Elsalini OA, Wendl T, Rohr KB (2006) Analysis of origin and growth of the thyroid gland in zebrafish. Dev Dyn 235(7):1872–1883. doi:10.1002/dvdy.20831 CrossRefPubMed

von Elsalini OA, Gartzen J, Cramer M, Rohr KB (2003) Zebrafish hhex, nk2.1a, and pax2.1 regulate thyroid growth and differentiation downstream of Nodal-dependent transcription factors. Dev Biol 263(1):67–80CrossRefPubMed

Wendl T, Lun K, Mione M, Favor J, Brand M, Wilson SW, Rohr KB (2002) Pax2.1 is required for the development of thyroid follicles in zebrafish. Development 129(15):3751–3760PubMed

Lazzaro D, Price M, de Felice M, Di Lauro R (1991) The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113(4):1093–1104PubMed

Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R (2002) Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 99(24):15462–15467. doi:10.1073/pnas.242328999 CrossRefPubMedPubMedCentral

10.

Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284(5415):770–776CrossRefPubMed

11.

Lai EC (2004) Notch signaling: control of cell communication and cell fate. Development 131(5):965–973. doi:10.1242/dev.01074 CrossRefPubMed

12.

Fiuza UM, Arias AM (2007) Cell and molecular biology of Notch. J Endocrinol 194(3):459–474. doi:10.1677/JOE-07-0242 CrossRefPubMed

13.

Bolos V, Grego-Bessa J, de la Pompa JL (2007) Notch signaling in development and cancer. Endocr Rev 28(3):339–363CrossRefPubMed

14.

Lorent K, Yeo SY, Oda T, Chandrasekharappa S, Chitnis A, Matthews RP, Pack M (2004) Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy. Development 131(22):5753–5766. doi:10.1242/dev.01411 CrossRefPubMed

15.

Dutta S, Dietrich JE, Westerfield M, Varga ZM (2008) Notch signaling regulates endocrine cell specification in the zebrafish anterior pituitary. Dev Biol 319(2):248–257. doi:10.1016/j.ydbio.2008.04.019 CrossRefPubMedPubMedCentral

16.

Fukuda A, Kawaguchi Y, Furuyama K, Kodama S, Horiguchi M, Kuhara T, Koizumi M, Boyer DF, Fujimoto K, Doi R, Kageyama R, Wright CV, Chiba T (2006) Ectopic pancreas formation in Hes1 -knockout mice reveals plasticity of endodermal progenitors of the gut, bile duct, and pancreas. J Clin Investig 116(6):1484–1493CrossRefPubMedPubMedCentral

17.

Zecchin E, Filippi A, Biemar F, Tiso N, Pauls S, Ellertsdottir E, Gnugge L, Bortolussi M, Driever W, Argenton F (2007) Distinct delta and jagged genes control sequential segregation of pancreatic cell types from precursor pools in zebrafish. Dev Biol 301(1):192–204. doi:10.1016/j.ydbio.2006.09.041 CrossRefPubMed

18.

Fagman H, Andersson L, Nilsson M (2006) The developing mouse thyroid: embryonic vessel contacts and parenchymal growth pattern during specification, budding, migration, and lobulation. Dev Dyn 235(2):444–455. doi:10.1002/dvdy.20653 CrossRefPubMed

19.

Opitz R, Maquet E, Zoenen M, Dadhich R, Costagliola S (2011) The TSH receptor is required for thyroid differentiation in zebrafish. Mol Endocrinol 25:1579–1599. doi:10.1210/me.2011-0046 CrossRefPubMedPubMedCentral

20.

Manfroid I, Delporte F, Baudhuin A, Motte P, Neumann CJ, Voz ML, Martial JA, Peers B (2007) Reciprocal endoderm–mesoderm interactions mediated by fgf24 and fgf10 govern pancreas development. Development 134(22):4011–4021. doi:10.1242/dev.007823 CrossRefPubMed

21.

Serls AE, Doherty S, Parvatiyar P, Wells JM, Deutsch GH (2005) Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung. Development 132(1):35–47. doi:10.1242/dev.01570 CrossRefPubMed

22.

Alt B, Elsalini OA, Schrumpf P, Haufs N, Lawson ND, Schwabe GC, Mundlos S, Gruters A, Krude H, Rohr KB (2006) Arteries define the position of the thyroid gland during its developmental relocalisation. Development 133(19):3797–3804. doi:10.1242/dev.02550 CrossRefPubMed

23.

Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128(19):3675–3683PubMed

24.

Fagman H, Liao J, Westerlund J, Andersson L, Morrow BE, Nilsson M (2007) The 22q11 deletion syndrome candidate gene Tbx1 determines thyroid size and positioning. Hum Mol Genet 16(3):276–285. doi:10.1093/hmg/ddl455 CrossRefPubMed

25.

Westerlund J, Andersson L, Carlsson T, Zoppoli P, Fagman H, Nilsson M (2008) Expression of Islet1 in thyroid development related to budding, migration, and fusion of primordia. Dev Dyn 237(12):3820–3829. doi:10.1002/dvdy.21772 CrossRefPubMed

26.

Dentice M, Cordeddu V, Rosica A, Ferrara AM, Santarpia L, Salvatore D, Chiovato L, Perri A, Moschini L, Fazzini C, Olivieri A, Costa P, Stoppioni V, Baserga M, De Felice M, Sorcini M, Fenzi G, Di Lauro R, Tartaglia M, Macchia PE (2006) Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab 91(4):1428–1433. doi:10.1210/jc.2005-1350 CrossRefPubMed

27.

Crosnier C, Attie-Bitach T, Encha-Razavi F, Audollent S, Soudy F, Hadchouel M, Meunier-Rotival M, Vekemans M (2000) JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 32(3):574–581. doi:10.1053/jhep.2000.16600 CrossRefPubMed

28.

High FA, Jain R, Stoller JZ, Antonucci NB, Lu MM, Loomes KM, Kaestner KH, Pear WS, Epstein JA (2009) Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue–tissue interactions during outflow tract development. J Clin Investig 119(7):1986–1996. doi:10.1172/JCI38922 PubMedPubMedCentral

29.

Wendl T, Adzic D, Schoenebeck JJ, Scholpp S, Brand M, Yelon D, Rohr KB (2007) Early developmental specification of the thyroid gland depends on han-expressing surrounding tissue and on FGF signals. Development 134(15):2871–2879. doi:10.1242/dev.02872 CrossRefPubMed

30.

Kurmann AA, Serra M, Hawkins F, Rankin SA, Mori M, Astapova I, Ullas S, Lin S, Bilodeau M, Rossant J, Jean JC, Ikonomou L, Deterding RR, Shannon JM, Zorn AM, Hollenberg AN, Kotton DN (2015) Regeneration of thyroid function by transplantation of differentiated pluripotent stem cells. Cell Stem Cell 17(5):527–542. doi:10.1016/j.stem.2015.09.004 CrossRefPubMedPubMedCentral

31.

Olivieri A, Stazi MA, Mastroiacovo P, Fazzini C, Medda E, Spagnolo A, De Angelis S, Grandolfo ME, Taruscio D, Cordeddu V, Sorcini M, Study Group for Congenital Hypothyroidism (2002) A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991–1998). J Clin Endocrinol Metab 87(2):557–562. doi:10.1210/jcem.87.2.8235 PubMed

32.

Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, Costa T, Pierpont ME, Rand EB, Piccoli DA, Hood L, Spinner NB (1997) Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16(3):243–251. doi:10.1038/ng0797-243 CrossRefPubMed

33.

de Filippis T, Gelmini G, Paraboschi E, Vigone MC, Di Frenna M, Marelli F, Bonomi M, Cassio A, Larizza D, Moro M, Radetti G, Salerno M, Ardissino D, Weber G, Gentilini D, Guizzardi F, Duga S, Persani L (2017) A frequent oligogenic involvement in congenital hypothyroidism. Hum Mol Genet 26(13):2507–2514. doi:10.1093/hmg/ddx145 CrossRefPubMed

Title: Role of Jagged1-Notch pathway in thyroid development
Authors: F. Marelli
L. Persani
Publication date: 01-01-2018
Publisher: Springer International Publishing
Published in: Journal of Endocrinological Investigation / Issue 1/2018
Electronic ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-017-0715-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Energy expenditure in the etiology of human obesity: spendthrift and thrifty metabolic phenotypes and energy-sensing mechanisms

Polyglandular autoimmune syndromes

The diagnostic value of glycated albumin in gestational diabetes mellitus

Unnoticed maternal Graves’ disease revealed by the baby’s low free thyroxine in newborn screening: an underestimated condition supporting thyroid disease screening among pregnant women

Does a male polycystic ovarian syndrome equivalent exist?

How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials